Long-term oral β-carotene supplementation in patients with cystic fibrosis - Effects on antioxidative status and pulmonary function
- Autor(en)
- Petra Rust, Irmgard Eichler, Sabine Renner, Ibrahim Elmadfa
- Abstrakt
To investigate the efficacy of long-term oral β-carotene supplementation for optimizing the antioxidant status and pulmonary function in patients with cystic fibrosis (CF), 24 patients (aged 12.8 ± 6.3 years) were randomized to a CF supplementation or to a CF placebo group. As controls 14 healthy age-matched subjects (aged 14.7 ± 6.2 years) were studied. Patients of the CF supplementation group received 1 mg β-carotene/kg body weight (BW)/day (maximally 50 mg β-carotene/day) for the first 12 weeks; during the following 12 weeks, dosage was reduced to 10 mg β-carotene/day. At study entry, plasma β-carotene concentrations were significantly lower in CF patients than in controls (p < 0.001). In the CF supplementation group, plasma β-carotene concentrations were significantly increased (baseline: 0.08 ± 0.04 μmol/l) at the end of high-dose treatment (12th week; 0.6 ± 0.4 μmol/l; p < 0.001), but decreased again during supplementation with 10 mg β-carotene/day to 0.3 ± 0.2 μmol/l at the end of the study (p < 0.001). β-Carotene supplementation did not affect plasma concentrations of other carotenoids and retinol, but an increase in plasma α- and γ-tocopherol concentrations was noticed. During high-dose treatment, a significant decrease in TBA-MDA complexes and a correction of total antioxidative capacity was observed. During the treatment, pulmonary exacerbation could be corrected significantly (p < 0.05). We conclude that CF patients can be efficiently supplemented with 1 mg β-carotene/kg BW/day (maximally 50 mg β-carotene/day) to achieve plasma concentrations of healthy control subjects and to minimize oxidative stress, improving the quality of life of CF patients. Copyright (C) 2000 S. Karger AG, Basel.
- Organisation(en)
- Department für Ernährungswissenschaften
- Externe Organisation(en)
- Allgemeines Krankenhaus der Stadt Wien (AKH)
- Journal
- Annals of Nutrition and Metabolism: European journal of nutrition, metabolic diseases and dietetics
- Band
- 44
- Seiten
- 30-37
- Anzahl der Seiten
- 8
- ISSN
- 0250-6807
- DOI
- https://doi.org/10.1159/000012818
- Publikationsdatum
- 01-2000
- Peer-reviewed
- Ja
- ÖFOS 2012
- 303009 Ernährungswissenschaften
- Schlagwörter
- ASJC Scopus Sachgebiete
- Medicine (miscellaneous), Nutrition and Dietetics
- Link zum Portal
- https://ucrisportal.univie.ac.at/de/publications/c9778d90-1bb1-444a-831c-7583b4951a46